← All trials
NCT06014073
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Sep 6, 2023
- Primary completion
- Sep 1, 2025
- Completion date
- Sep 1, 2026
- First posted
- Aug 28, 2023
- Last posted
- Sep 11, 2023
- Enrollment
- 30
- Arms / groups
- 1 / —
- Source
- AACT · ctgov ingestion
Sponsors
- People's Liberation Army of ChinaLead sponsor
- People's Liberation Army of ChinaOverall official - principal investigator
- People's Liberation Army of ChinaReponsible party - principal investigator
- Peking UniversityCollaborator
- People's Liberation Army of ChinaSponsor investigator
- EdiGene (GuangZhou) Inc.Collaborator
- People's Liberation Army of ChinaOfficial
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.